Y200-2685 Screening compound: 7-bromo-2-(4-ethylphenyl)quinoline-4-carboxylic acid

Y200-2685 Screening compound: 7-bromo-2-(4-ethylphenyl)quinoline-4-carboxylic acid
Y200-2685 Screening compound: 7-bromo-2-(4-ethylphenyl)quinoline-4-carboxylic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-2685
7-bromo-2-(4-ethylphenyl)quinoline-4-carboxylic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-2685

Molecular Formula

C18H14BrNO2 (C18 H14 BrNO2)

Compound Name

7-bromo-2-(4-ethylphenyl)quinoline-4-carboxylic acid

IUPAC name

7-bromo-2-(4-ethylphenyl)quinoline-4-carboxylic acid

SMILES

CCc(cc1)ccc1-c1cc(C(O)=O)c(ccc(Br)c2)c2n1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

356.22

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

3

Partition Coefficient, logP

6.276

Distribution Coefficient, logD

1.220

Water Solubility, LogSw

-5.47

Polar Surface Area

36.706

Acid Dissociation Constant (pKa)

2.94

Base Dissociation Constant (pKb)

4.03

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

11.10

Y200-2685 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

Antiviral Library (67538 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

SmartTM Library (51161 compounds)

Antibacterial Compounds Library (13827 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
  • Infections
  • Immune system
  • animal
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Targets:
  • Nuclear receptors

References: we are preparing a list of scientific research reports with Y200-2685 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-2685?
Check Price and Availability of Y200-2685, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-2685 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-2685
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-2685
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-2685 available by request